Rafferty Asset Management
SPPI

Rafferty Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Rafferty Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-690,370
Closed -$1.5M – 1343
2021
Q3 		$1.5M Buy
690,370
+328,088
+91% +$896K 0.01% 709
2021
Q2 		$1.36M Sell
362,282
-221,956
-38% -$771K 0.01% 789
2021
Q1 		$1.91M Buy
584,238
+491,733
+532% +$1.76M 0.01% 642
2020
Q4 		$315K Sell
92,505
-13,992
-13% -$57.6K ﹤0.01% 798
2020
Q3 		$435K Buy
106,497
+50,983
+92% +$194K 0.01% 727
2020
Q2 		$188K Buy
+55,514
New +$162K ﹤0.01% 931
2020
Q1 		– Sell
-84,164
Closed -$306K – 846
2019
Q4 		$306K Sell
84,164
-39,775
-32% -$321K ﹤0.01% 787
2019
Q3 		$1.03M Sell
123,939
-53,049
-30% -$429K 0.02% 535
2019
Q2 		$1.52M Sell
176,988
-19,396
-10% -$173K 0.03% 480
2019
Q1 		$2.1M Buy
+196,384
New +$2.1M 0.03% 362

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rafferty Asset Management's SPPI Position: Q4 2021 in Review

Rafferty Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 690,370 shares — an estimated $1.5M sold.

Rafferty Asset Management first reported a position in SPPI in Q1 2019 and held it in 10 quarters. The position peaked at $2.1M in Q1 2019. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

  • Rafferty Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 690,370 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $1.5M.
  • Rafferty Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 10 quarters.
  • Rafferty Asset Management's Spectrum Pharmaceuticals Inc position peaked at $2.1M in Q1 2019.
  • 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.